• OPEN AN ACCOUNT
Indian Indices
Sensex
76,152.86 -417.49
( -0.55%)
Global Indices
Nasdaq
53,682.77 599.82
(1.13%)
Dow Jones
7,765.55 77.95
(1.01%)
Hang Seng
64,337.38 11.74
(0.02%)
Nikkei 225
10,831.87 75.42
(0.70%)
Forex
USD-INR
94.95 -0.29
(-0.30%)
EUR-INR
110.11 -0.38
(-0.35%)
GBP-INR
128.48 -0.52
(-0.40%)
JPY-INR
0.59 0.00
(-0.47%)

EQUITY - MARKET SCREENER

Steel Exchange India Ltd
Industry :  Steel - Medium / Small
BSE Code
ISIN Demat
Book Value()
534748
INE503B01021
4.4143929
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STEELXIND
45.32
1445.16
EPS(TTM)
Face Value()
Div & Yield %
0.25
1
0
 

Jenburkt Pharmaceuticals standalone net profit declines 24.39% in the June 2026 quarter
Aug 07,2026
Net profit of Jenburkt Pharmaceuticals declined 24.39% to Rs 5.89 crore in the quarter ended June 2026 as against Rs 7.79 crore during the previous quarter ended June 2025. Sales declined 0.06% to Rs 35.51 crore in the quarter ended June 2026 as against Rs 35.53 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales35.5135.53 0
OPM %16.9825.19 -
PBDT7.4110.90 -32
PBT6.7710.18 -33
NP5.897.79 -24